Use of Ashwagandha on Covid warriors: BHU to study
Published By : Prameya News Bureau | July 13, 2020 IST
Share
Varanasi, July 13: The Institute of Medical Sciences (IMS) in the Banaras Hindu University (BHU) will study the use of Ashwagandha (Withania somnifera) as a test drug for prophylactic use among frontline health workers and Yashtimadhu (Glycyrrhiza glabra) for supplementary therapy as a standard treatment of Corona patients with mild and moderate symptoms.According to Professor Anand Chaudhary, head of the department of Rasa Shastra, of Ayurveda faculty IMS-BHU and centre coordinator for the project, "As a part of the project of ministry of AYUSH, Indian Council of Medical Research and Council of Scientific and Industrial Research, the university was assigned the task of conducting studies on Ashwagandha and Yashtimadhu."He said, "Ashwagandha will be tested for study in prophylactic use among frontline health workers of SSL Hospital of BHU and other healthcare workers, while Yashtimadhu will be tested as drug for adjunct therapy with the standard treatment of conventional medicine on Covid-19 patients under treatment in BHU with mild and moderate symptoms."Chaudhary said, "The ministry, ICMR and CSIR have selected Cadila Pharmaceutical Limited, Ahmedabad and Ardent Clinical Research Services, Pune, as contract research organization (CRO) and nodal agencies for the projects of prophylaxis and adjunct therapy, respectively, to take care of the projects sanctioned to the BHU and other medical institutions in Lucknow, Bengaluru, Mumbai, Thiruvananthapuram, Gurugram, Jodhpur and Jaipur."The objectives of the projects are to explore the efficacy of ayurvedic interventions in Covid-19 patients on standards of conventional biomedical researches, he said, adding that each centre has formed joint teams of investigators from both allopathy and ayurvedic faculties.Prof Chaudhary said the consignment of Ashwagandha and Yashtimadhu has been received by BHU while funds for further studies and data collection to be done in six weeks, are expected to be allocated within a week.He said that the compiled data of these studies will be submitted for validation on contemporary scientific standards by global health agencies like WHO for the acceptance of Ayurveda as a system of medicine worldwide.BHU, which is among 15 institutions of the country to contribute in this project, is providing level-3 facility at its hospitals for Covid-19 patients while it is also conducting laboratory testing for novel coronavirus infection of many east Uttar Pradesh districts. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
AIIMS Bhubaneswar introduces specialized unit for heat stroke patients
Conquering Anxiety: Insights from Psychiatry Prof. Dr. Surjeet Sahoo
SUM Ultimate Medicare (SUMUM) receives JCI prime certification
Know strategies to overcome social anxiety
SUM Hospital conducts Odisha’s first haploidentical hematopoitic stem transplantation
The silent storm: How stress wreaks havoc on your body
More than 5 grams of artificial sweetener saccharin a day can be fatal: Doctors
Low vision clinic inaugurated at AIIMS Bhubaneswar
Loneliness can cause an extreme desire for sugary foods: Study
Experts urge parents to wean children off social media
HK, Singapore food regulators red flag ‘cancer-causing’ ingredient in certain MDH, Everest spices
SUP’ORT training program for physiotherapists held at SUMUM
Patient awareness and interaction programme marks World Liver Day at AIIMS Bhubaneswar
Rising cases of pediatric liver issues linked to junk food epidemic
Vital organ, vital importance: Why maintaining liver health matters
World Liver Day 2024: These factors contribute to liver damage
Nestle baby food sugar study causes concern in India, Nestle India's shares fall
World Voice Day observed at SUM Phulnakhara Campus
Cadaveric kidney transplant performed at SCB Hospital
Closure of regn counter sparks tension at Bhubaneswar AIIMS